A Study of Electronic Clinical Decision Support Tools for Steatotic Liver Disease
ConditionMASLD
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorVanderbilt University Medical Center
About this trial
The overall objectives of this study are to determine the effectiveness of a participant-specific guided electronic decision support system on provider decision making for participants with metabolic-dysfunction associated steatotic liver disease (MASLD), and to determine the acceptance and barriers for use of an electronic health record embedded algorithm for MASLD care management within ambulatory primary care, endocrinology, and general gastroenterology settings.
Eligibility criteria
Qualifiers
Adult patients (age ≥ 18 years)
Outpatient clinic visit (in-person or telemedicine) at a participating clinic site
Demonstrated Screening Need due to High Risk Profile, which includes the following: Diagnostic Codes for MASLD or Hepatic Steatosis on Imaging PLUS at least one cardiometabolic risk factors; OR Chronically Elevated Liver Enzymes (> 6 months); OR patient with impaired glycemic control (prediabetes/diabetes); OR 2 or more cardiometabolic risk factors present
Disqualifiers
Solid Organ Transplant Recipient
Existing Hepatology Relationship Evidenced by Prior Hepatology Visit Within 3 Years
Active Cancer Diagnoses
Diagnoses for Alcohol-Related Conditions
Trial design
Treatments tested in this trial
- eMPOWER Decision Aid
Treatment groups
7,200 Participants
are divided into 2 treatment groupsLocations
1Vanderbilt University Medical Center37232, NashvilleTennessee, United States
Sponsors and collaborators
Vanderbilt University Medical Center
Lead sponsor
American Association for the Study of Liver Diseases
Collaborator
Source ClinicalTrials.gov